Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice (Q28260292)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice |
scientific article |
Statements
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice (English)
0 references
January 2007
0 references
81
0 references
1
0 references
100-7
0 references